|You're receiving this email as a valued member of the International Academy of Compounding Pharmacists. Having trouble viewing this email? View it in your browser.
IACP Member Alert
November 13, 2012
IACP to Participate in U.S. Senate Committee Hearing on the Implications of the 2012 Meningitis Outbreak
David G. Miller, RPh, IACP Executive Vice President & CEO, will testify during the U.S. Senate HELP Committee hearing, “Pharmacy Compounding: Implications of the 2012 Meningitis Outbreak” on November 15, 2012 at 10 am EST, in 106 Dirksen Senate Office Building in Washington, D.C.
Please click here for more information on the Hearing and its panel participants.
“IACP appreciates the opportunity to provide input as the U.S. Senate HELP Committee seeks to better understand current federal and state oversight of pharmacy compounding and explore the possibilities for a legislative solution to the tragedy surrounding New England Compounding Center (NECC) business practices,” said IACP Vice President of Government Affairs Sarah Dodge. “We believe we share similar goals: an understanding of how this tragedy happened, what can be done to prevent it from ever happening again, and ultimately how do we assure that compounding pharmacists are able to practice their professional expertise without overly burdensome regulations which inhibit quality patient care."
Stay tuned to C-SPAN TV schedule listings for a chance to watch David G. Miller, RPh, LIVE at the U.S. Senate Committee on November 15, 2012. Televised programs are typically announced the evening before the scheduled air date. Click here to view C-CPAN live TV schedule.
In addition to the U.S. Senate Hearing, the House Energy & Commerce Committee will hold its own hearing on November 14, 2012. Click here to view the extensive hearing backgrounder which details a decade of practice standard and regulatory violations by NECC. Of particular interest to all IACP members is that this provides clear and irrefutable evidence of what your Academy has been saying since the tragedy first became public – the regulators, specifically the state Board of Pharmacy and the FDA which are responsible for protecting public safety, simply failed to do their job. For more information, click here.
Click here to view the House Energy & Commerce Committee hearing live on C-SPAN at 10:00 am EST on November 14, 2012.
The Academy will update the IACP Membership on both of these hearings in future communications.
IACP wants to make certain that messaging about the practice of pharmacy compounding remains both consistent and factual. If your practice receives any calls from the media, we encourage you to refer them to IACP’s PR firm. Our public relations firm works not only for the association as a whole but also for you as an individual member. Please direct media to:
David A. Ball
Ball Consulting Group, LLC
One Gateway Center, Suite 406
Newton, MA 02458
|4638 Riverstone Blvd., Missouri City, TX 77459
email@example.com | Phone: 281-933-8400 | Toll-Free Referral Line: 800-927-4227
Click here to unsubscribe.
© 2012 International Academy of Compounding Pharmacists. All Rights Reserved.